Received: 7 October 2021
Accepted: 26 May 2022
First Online: 3 June 2022
: The study was approved by the Ethics Committee of Veneto Institute of Oncology (CESC-IOV) on 03 February 2015. All methods were performed in accordance with with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study in accordance with the relevant guidelines and regulations of CESC-IOV.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.